Physician profile
Bobby D Perry
NPI 1528064821
$7,334.04
in general payments reported to CMS, 2019-2025
25 companies · $5,340 in 2025
The $5,340 reported for 2025 was more than what 91% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $544 · 2020: $76.97 · 2021: $117 · 2022: $94.91 · 2023: $157 · 2024: $1,005 · 2025: $5,340.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,000 · Travel and Lodging: $1,531 · Food and Beverage: $971.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,000.00 |
| Travel and Lodging | $1,530.66 |
| Food and Beverage | $970.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,085.86 | 2024-2025 | |
| Smith+Nephew, INC. | $167.67 | 2019-2023 | Renasys Go V2 Home |
| Kci USA, INC. | $130.85 | 2019 | |
| Tela Bio, INC. | $120.03 | 2023-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Zyla Life Sciences, INC. | $113.70 | 2019 | |
| Polynovo North America LLC | $89.37 | 2022-2023 | |
| Ethicon US, LLC | $66.68 | 2019-2022 | |
| Acell, INC. | $65.99 | 2019-2020 | |
| Integra Lifesciences Corporation | $55.63 | 2020-2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Baudax Bio INC. | $54.80 | 2021 | |
| Merck Sharp & Dohme LLC | $49.22 | 2019-2022 | |
| Medtronic USA, INC. | $43.15 | 2020 | |
| Medline Industries Lp | $33.26 | 2019 | |
| Myriad Genetic Laboratories, INC. | $33.25 | 2025 | Myrisk |
| Edwards Lifesciences Corporation | $26.92 | 2024 | Hemosphere |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $25.80 | 2024 | Quikclot |
| Urgo Medical North America, LLC | $25.47 | 2023 | Urgok2, Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Davol INC. | $24.93 | 2022 | |
| Innovation Technologies INC | $24.93 | 2025 | Irrisept |
| Abbvie INC. | $20.04 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $18.76 | 2023 | Gattex |
| Solventum Corporation | $18.68 | 2025 | Prevena, V.A.C. Veraflo Cleanse Choice, Abthera |
| Janssen Pharmaceuticals, INC | $16.88 | 2021 | |
| Bard Access Systems, INC. | $11.28 | 2019 | |
| Boston Scientific Corporation | $10.89 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bobby Perry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.